CJC-1295 (DAC) 5 mg

CJC-1295 (with DAC) 5mg is a synthetic research peptide studied for its role in growth hormone–related signaling pathways. It is a modified analogue of growth hormone releasing hormone (GHRH) designed to extend activity through the addition of a Drug Affinity Complex (DAC), allowing for prolonged interaction within biological systems. Researchers are interested in CJC-1295 (with DAC) due to its ability to support sustained signaling associated with growth hormone release and downstream regulatory pathways. This compound remains investigational and is supplied strictly for laboratory research.

Key Research Attributes

• Single research peptide compound
• Modified GHRH analogue with extended activity (DAC)
• Studied in growth hormone and endocrine signaling models
• Lyophilized powder format
• Supplied strictly for laboratory research only

Why Researchers Are Interested

• Being studied for sustained growth hormone signaling pathways
• Researchers explore its influence on endocrine and regulatory systems
• May help investigate prolonged receptor activation and downstream signaling
• Often discussed in growth, recovery, and metabolic research models
• Has drawn attention as a long-acting GHRH analogue for extended signaling studies

This product is intended strictly for laboratory research purposes.
Not for human or veterinary use.